Everand Logo

Welcome to Everand!

  • STAT

    They study gambling disorder. And they had a lot on their minds at a conference in Las Vegas

    When researchers studying gambling disorder met in Las Vegas, they asked tough questions about hormones, help hotlines, and risk-loving rats.
    by Rebecca Robbins Oct 06, 2017 4 minutes

    LAS VEGAS — What happens when scientists who study gambling addiction descend on a casino-sponsored medical conference?

    I went to the Las Vegas Strip to find out.

    It wasn’t your typical Sin City trip. Upstairs, in the Venetian and Palazzo casinos, slot machines whirred and roulette wheels spun. In our conference room, meanwhile, researchers debated diagnostic categories and pondered brain scans. At one point, they all closed their eyes for a group meditation.

    The conference this week was shadowed, of course, by grief and shock at the mass shooting that left 59 people dead and more than 500 injured at a country music festival just a couple

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
    Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

    Related Books & Audiobooks